1. Home
  2. EEIQ vs NXTC Comparison

EEIQ vs NXTC Comparison

Compare EEIQ & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EEIQ
  • NXTC
  • Stock Information
  • Founded
  • EEIQ 2017
  • NXTC 2015
  • Country
  • EEIQ United States
  • NXTC United States
  • Employees
  • EEIQ N/A
  • NXTC N/A
  • Industry
  • EEIQ Other Consumer Services
  • NXTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • EEIQ Real Estate
  • NXTC Health Care
  • Exchange
  • EEIQ Nasdaq
  • NXTC Nasdaq
  • Market Cap
  • EEIQ 12.1M
  • NXTC 13.0M
  • IPO Year
  • EEIQ 2021
  • NXTC 2019
  • Fundamental
  • Price
  • EEIQ $0.52
  • NXTC $5.71
  • Analyst Decision
  • EEIQ
  • NXTC Strong Buy
  • Analyst Count
  • EEIQ 0
  • NXTC 2
  • Target Price
  • EEIQ N/A
  • NXTC $25.50
  • AVG Volume (30 Days)
  • EEIQ 12.7M
  • NXTC 16.7K
  • Earning Date
  • EEIQ 08-21-2025
  • NXTC 11-06-2025
  • Dividend Yield
  • EEIQ N/A
  • NXTC N/A
  • EPS Growth
  • EEIQ N/A
  • NXTC N/A
  • EPS
  • EEIQ N/A
  • NXTC N/A
  • Revenue
  • EEIQ $9,358,301.00
  • NXTC N/A
  • Revenue This Year
  • EEIQ N/A
  • NXTC N/A
  • Revenue Next Year
  • EEIQ N/A
  • NXTC N/A
  • P/E Ratio
  • EEIQ N/A
  • NXTC N/A
  • Revenue Growth
  • EEIQ 44.99
  • NXTC N/A
  • 52 Week Low
  • EEIQ $0.42
  • NXTC $2.69
  • 52 Week High
  • EEIQ $1.74
  • NXTC $19.20
  • Technical
  • Relative Strength Index (RSI)
  • EEIQ 47.11
  • NXTC 65.16
  • Support Level
  • EEIQ $0.48
  • NXTC $4.77
  • Resistance Level
  • EEIQ $0.56
  • NXTC $5.15
  • Average True Range (ATR)
  • EEIQ 0.06
  • NXTC 0.25
  • MACD
  • EEIQ -0.01
  • NXTC 0.07
  • Stochastic Oscillator
  • EEIQ 21.95
  • NXTC 89.62

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S., Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. Company operated in three primary reportable segments foreign language education (QHI), foreign language education (RIL) and the professional training programs.

About NXTC NextCure Inc.

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

Share on Social Networks: